OM1 Stock
HealthTechLooking to sell OM1 stock or options?
Contact usFounded: 2014Funding to Date: $176M
Visit websiteOM1 is the developer of an outcome management platform that is engineered to produce, compare, and anticipate treatment outcomes. The platform of this company collects, refines, enhances, and utilizes clinical data to offer AI-powered insights and predictions that can optimize clinical, financial, and administrative management. This enables healthcare institutions to examine and employ outcomes data in a clinically relevant and accurate manner.
Investors Include:
Breyer Capital, D1 Capital Partners, General Catalyst, Polaris Partners, Koa Labs, Kaiser Permanente, Wanxiang Healthcare Investments, Scale Venture Partners, 7wireVentures, Glikvest.